Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques (CSH) dans le traitement des cancers du sein de mauvais pronostic : situation actuelle et perspectives futures = Treatment intensification and hematopoietic stem cell autograft in the treatment of breast cancer with bad prognosis : present state and perspectiveLOTZ, J.-P.Oncologie (Paris). 2000, Vol 2, Num 5, pp 269-275, issn 1292-3818Article

Évaluation des pratiques de prescription de chimiothérapies anticancéreuses à des stades métastatiques avancés: résultats d'une étude pilote = Evaluation of prescription practices for chemotherapy for advanced, metastatic cancer: results of a pilot studyDEBRIX, I; FILLON, J; BOUKARI, Y et al.Oncologie (Paris). 2013, Vol 15, Num 10-11, pp 548-554, issn 1292-3818, 7 p.Article

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancerMAINDRAULT-GOEBEL, F; DE GRAMONT, A; ARTRU, P et al.Annals of oncology. 2000, Vol 11, Num 11, pp 1477-1483, issn 0923-7534Article

A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumorsTHEODORE, C; CHEVREAU, C; YATAQHENE, Y et al.Annals of oncology. 2008, Vol 19, Num 8, pp 1465-1469, issn 0923-7534, 5 p.Article

Spécificités de la chimiothérapie chez le sujet âgé : Pharmacologie = Chemotherapy for the elderlyAVENIN, D; SELLE, F; GLIGOROV, J et al.Oncologie (Paris). 2007, Vol 9, Num 11, pp 783-789, issn 1292-3818, 7 p.Article

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas : the ITOV 01 protocolLOTZ, J.-P; PAUTIER, P; RIBRAG, V et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 7, pp 669-675, issn 0268-3369, 7 p.Article

Analogues de la LHRH : leur utilisation dans le traitement du cancer du sein en situation métastatique et adjuvante = The use of GnRH analogues in early and advanced breast carcinomasSEGURAL, C; AVENIN, D; GLIGOROV, J et al.Gynécologie obstétrique & fertilité. 2005, Vol 33, Num 11, pp 914-919, issn 1297-9589, 6 p.Article

SABCS 2003 : 26^e édition pour de nouveaux standards en situation non métastatique ? = SABCS 2003 : 26th edition for new standards in non metastatic breast cancerGLIGOROV, J; DEBOURDEAU, P; ARSOVSKI, O et al.Oncologie (Paris). 2004, Vol 6, pp 113-122, issn 1292-3818, 10 p., SUP3Article

High-dose chemotherapy for ovarian carcinoma : Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)LEDERMANN, J. A; HERD, R; ROSTI, G et al.Annals of oncology. 2001, Vol 12, Num 5, pp 693-699, issn 0923-7534Article

Tandem high-dose chemotherapy wiht ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinomaLOTZ, J.-P; BOULEUC, C; ANDRE, T et al.Cancer. 1996, Vol 77, Num 12, pp 2550-2559, issn 0008-543XArticle

High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseTOURANI, J.-M; LEVY, R; LEMEVEL, A et al.Journal of clinical oncology. 1992, Vol 10, Num 7, pp 1086-1094, issn 0732-183XArticle

Place de l'hystérectomie d'emblée dans la prise en charge des tumeurs trophoblastiques gestationnelles à bas risque : Actualités sur les tumeurs de l'ovaire et les maladies trophoblastiques gestationnelles = Hysterectomy in Case of Low-Risk Gestational Trophoblastic Neoplasia : An Update on Ovarian Tumours and Gestational Trophoblastic DiseasesMASSARDIER, J; MATHE, M; BOLZE, P.-A et al.Oncologie (Paris). 2014, Vol 16, Num 6, pp 285-290, issn 1292-3818, 6 p.Article

Bilan des traitements ciblés de la phase métastatique : quelles perspectives pour demain ?GLIGOROV, J; KHALIL, A; SELLE, F et al.Société française de sénologie et de pathologie mammaire. Journées. 2007, pp 159-163, isbn 978-2-287-72614-9, 1Vol, 5 p.Conference Paper

Tumeurs rares malignes de l'ovaire : Les cancers de l'ovaire (1re partie) = Rare malignant ovarian tumoursRAY-COQUARD, I; GUASTALLA, J.-P; RAUDRANT, D et al.Oncologie (Paris). 2005, Vol 7, Num 7, pp 556-563, issn 1292-3818, 8 p.Article

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancerTOUBOUL, E; BUFFAT, L; PENE, F et al.International journal of radiation oncology, biology, physics. 1999, Vol 43, Num 1, pp 25-38, issn 0360-3016Article

Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques (CSH) dans le traitement des cancers du sein métastatiques : résultats du programme national Pegase 04 = Treatment intensification and autologous hematopoietic stem cell transplantation in the treatment of metastatic breast cancer : results of the national program Pegase 04LOTZ, J.-P; CURE, H; JANVIER, M et al.Hematology and cell therapy (Print). 1999, Vol 41, Num 2, pp 71-74, issn 1269-3286Conference Paper

Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapyHEINZLEF, O; LOTZ, J.-P; ROULLET, E et al.Journal of neurology, neurosurgery and psychiatry. 1998, Vol 64, Num 5, pp 667-669, issn 0022-3050Conference Paper

5-Fluorouracil combined with the [6S]-steroisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinomaMACHOVER, D; GRISON, X; GUILLOT, T et al.Annals of oncology. 1993, Vol 4, pp 29-35, issn 0923-7534, SUP2Conference Paper

Intensité de dose dans le traitement du cancer du sein : Greffes et Cancer = Dose intensity in the treatment of breast cancerSAINTIGNYL, P; SELLE, F; GLIGOROV, J et al.Oncologie (Paris). 2007, Vol 9, Num 12, pp 814-820, issn 1292-3818, 7 p.Article

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer : a phase II multicentre studyGONCALVES, A; DELVA, R; FABBRO, M et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 7, pp 651-659, issn 0268-3369, 9 p.Article

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trialLOTZ, J.-P; BUI, B; DUCLOS, B et al.Annals of oncology. 2005, Vol 16, Num 3, pp 411-418, issn 0923-7534, 8 p.Article

Les chimiothérapies à hautes doses dans les adénocarcinomes ovariens = High dose chemotherapy for ovarian cancerLOTZ, J.-P; LHOMME, C; PAUTIER, P et al.Bulletin du cancer. 2000, Vol 87, Num 1, pp 63-69, issn 0007-4551Article

Autogreffe de cellules souches hématopoiétiques après intensification thérapeutique dans les cancers du sein non inflammatoires = Autologous hematopoietic stem cell transplantation in breast cancerGISSELBRECHT, C; LOTZ, J.-P; MORVAN, F et al.Reproduction humaine et hormones. 1999, Vol 12, Num 1, pp 70-73, issn 0994-3919Article

High-dose chemotherapy followed by reinfusion of selected CD34⁺ peripheral blood cells in patients with poor-prognosis breast cancer : a randomized multicentre studyCHABANNON, C; CORNETTA, K; BURTNESS, B et al.British journal of cancer. 1998, Vol 78, Num 7, pp 913-921, issn 0007-0920Article

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adultsLOTZ, J.-P; ANDRE, T; DONSIMONI, R et al.Cancer. 1995, Vol 75, Num 3, pp 874-885, issn 0008-543XArticle